Cargando…

3-Bromopyruvate overcomes cetuximab resistance in human colorectal cancer cells by inducing autophagy-dependent ferroptosis

Colorectal cancer (CRC) remains a leading cause of cancer-related death worldwide. Cetuximab, in combination with chemotherapy, is effective for treating patients with wild-type KRAS/BRAF metastatic CRC (mCRC). However, intrinsic or acquired drug resistance often limits the use of cetuximab. In this...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mu, Mingchao, Zhang, Qin, Zhao, Chenye, Li, Xiaopeng, Chen, Zilu, Sun, Xuejun, Yu, Junhui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group US 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10581902/ https://www.ncbi.nlm.nih.gov/pubmed/37558749 http://dx.doi.org/10.1038/s41417-023-00648-5

Ejemplares similares

A Novel EGFR Targeted Immunotoxin Based on Cetuximab and Type 1 RIP Quinoin Overcomes the Cetuximab Resistance in Colorectal Cancer Cells
por: Landi, Nicola, et al.
Publicado: (2023)

Targeting Tyrosine Phosphatases by 3-Bromopyruvate Overcomes Hyperactivation of Platelets from Gastrointestinal Cancer Patients
por: Faria, Alessandra V. S., et al.
Publicado: (2019)

The effect of 3-bromopyruvate on human colorectal cancer cells is dependent on glucose concentration but not hexokinase II expression
por: Ho, Nelson, et al.
Publicado: (2016)

Identification and validation of COX-2 as a co-target for overcoming cetuximab resistance in colorectal cancer cells
por: Lu, Yang, et al.
Publicado: (2016)

Metabolic reprogramming, autophagy, and ferroptosis: Novel arsenals to overcome immunotherapy resistance in gastrointestinal cancer
por: Wang, Xiangwen, et al.
Publicado: (2023)

Synergistic Effect of 3-Bromopyruvate in Combination with Rapamycin Impacted Neuroblastoma Metabolism by Inhibiting Autophagy
por: Gan, Lei, et al.
Publicado: (2020)

Harnessing Ferroptosis to Overcome Drug Resistance in Colorectal Cancer: Promising Therapeutic Approaches
por: Cheng, Xiaofei, et al.
Publicado: (2023)

PRSS contributes to cetuximab resistance in colorectal cancer
por: Tan, Zhaoli, et al.
Publicado: (2020)

3-Bromopyruvate Suppresses the Malignant Phenotype of Vemurafenib-Resistant Melanoma Cells
por: Vital, Patrik da Silva, et al.
Publicado: (2022)

Combination RSL3 Treatment Sensitizes Ferroptosis- and EGFR-Inhibition-Resistant HNSCCs to Cetuximab
por: Liu, Shujie, et al.
Publicado: (2022)

3-Bromopyruvate as an Alternative Option for the Treatment of Protothecosis
por: Jagielski, Tomasz, et al.
Publicado: (2018)

Expression of neurofibromin 1 in colorectal cancer and cetuximab resistance
por: Tak, Eunyoung, et al.
Publicado: (2022)

Autophagy-dependent ferroptosis in kidney disease
por: Yang, Yuanting, et al.
Publicado: (2023)

Aurora Kinase Inhibition Overcomes Cetuximab Resistance in Squamous Cell Cancer of the Head and Neck
por: Hoellein, Alexander, et al.
Publicado: (2011)

The Panitumumab EGFR Complex Reveals a Binding Mechanism That Overcomes Cetuximab Induced Resistance
por: Sickmier, E. Allen, et al.
Publicado: (2016)

Transport of 3-bromopyruvate across the human erythrocyte membrane
por: Sadowska-Bartosz, Izabela, et al.
Publicado: (2014)

3-bromopyruvate and buthionine sulfoximine effectively kill anoikis-resistant hepatocellular carcinoma cells
por: Lee, Minjong, et al.
Publicado: (2017)

Overcoming Intrinsic and Acquired Cetuximab Resistance in RAS Wild-Type Colorectal Cancer: An In Vitro Study on the Expression of HER Receptors and the Potential of Afatinib
por: De Pauw, Ines, et al.
Publicado: (2019)

Inhibition of CDK1 Overcomes Oxaliplatin Resistance by Regulating ACSL4‐mediated Ferroptosis in Colorectal Cancer
por: Zeng, Kaixuan, et al.
Publicado: (2023)

Mechanisms underlying 3-bromopyruvate-induced cell death in colon cancer
por: Sun, Yiming, et al.
Publicado: (2015)

Overcoming acquired resistance to cetuximab by dual targeting HER family receptors with antibody-based therapy
por: Iida, Mari, et al.
Publicado: (2014)

Unleashing Ferroptosis in Human Cancers: Targeting Ferroptosis Suppressor Protein 1 for Overcoming Therapy Resistance
por: Lee, Jaewang, et al.
Publicado: (2023)

Targeting prominin2 transcription to overcome ferroptosis resistance in cancer
por: Brown, Caitlin W, et al.
Publicado: (2021)

Cetuximab in the management of colorectal cancer
por: Lenz, Heinz-Josef
Publicado: (2007)

Construction and Evaluation of Folic Acid-Modified 3-Bromopyruvate Cubosomes
por: Hou, Fangyan, et al.
Publicado: (2020)

In vitro and in vivo effects of 3-bromopyruvate against Echinococcus metacestodes
por: Xin, Qi, et al.
Publicado: (2019)

Mitochondrial Function Are Disturbed in the Presence of the Anticancer Drug, 3-Bromopyruvate
por: Cal, Magdalena, et al.
Publicado: (2021)

Combinative treatment of β-elemene and cetuximab is sensitive to KRAS mutant colorectal cancer cells by inducing ferroptosis and inhibiting epithelial-mesenchymal transformation
por: Chen, Peng, et al.
Publicado: (2020)

A pan-cancer analysis of molecular characteristics and oncogenic role of gasdermins
por: Mu, Mingchao, et al.
Publicado: (2022)

Negative correlation between acetyl-CoA acyltransferase 2 and cetuximab resistance in colorectal cancer: Correlation between ACAA2 and cetuximab resistance in CRC
por: Yuan, Yitao, et al.
Publicado: (2023)

Inducing ferroptosis has the potential to overcome therapy resistance in breast cancer
por: Qi, Xiaowen, et al.
Publicado: (2022)

Autophagy-dependent ferroptosis as a potential treatment for glioblastoma
por: Xie, Yangchun, et al.
Publicado: (2023)

Differentiate or Die: 3-Bromopyruvate and Pluripotency in Mouse Embryonic Stem Cells
por: Rodrigues, Ana Sofia, et al.
Publicado: (2015)

Targeting Cancer Cells using 3-bromopyruvate for Selective Cancer Treatment
por: Baghdadi, Hussam H.
Publicado: (2017)

Delphinidin Increases the Sensitivity of Ovarian Cancer Cell Lines to 3-bromopyruvate
por: Pieńkowska, Natalia, et al.
Publicado: (2021)

Genomic characterization of intrinsic and acquired resistance to cetuximab in colorectal cancer patients
por: Bray, Steven M., et al.
Publicado: (2019)

The HK2 Dependent “Warburg Effect” and Mitochondrial Oxidative Phosphorylation in Cancer: Targets for Effective Therapy with 3-Bromopyruvate
por: Lis, Paweł, et al.
Publicado: (2016)

SLC38A5 Modulates Ferroptosis to Overcome Gemcitabine Resistance in Pancreatic Cancer
por: Kim, Myeong Jin, et al.
Publicado: (2023)

Laser-activatable oxygen self-supplying nanoplatform for efficiently overcoming colorectal cancer resistance by enhanced ferroptosis and alleviated hypoxic microenvironment
por: Jiang, Hao, et al.
Publicado: (2023)

Cetuximab promotes RSL3-induced ferroptosis by suppressing the Nrf2/HO-1 signalling pathway in KRAS mutant colorectal cancer
por: Yang, Jiawen, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_do7e24lhhjs076e6bv2edjkh8h